Literature DB >> 6017510

Assessment of possible glucocorticoid activity of carbenoxolone sodium.

M J Fletcher, N MacKay, C D Forbes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6017510      PMCID: PMC1841531          DOI: 10.1136/bmj.1.5537.412

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  BIOGASTRONE IN INPATIENT TREATMENT OF GASTRIC ULCER: A DOUBLE-BLIND STUDY.

Authors:  W R MIDDLETON; A R COOKE; D STEPHEN; A P SKYRING
Journal:  Lancet       Date:  1965-05-15       Impact factor: 79.321

2.  Laryngeal spill-over.

Authors:  T L BRADBER
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

3.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

4.  Effects of liquorice and its derivatives on salt and water metabolism.

Authors:  W I CARD; W MITCHELL; J A STRONG; N R W TAYLOR; S L TOMPSETT; J M G WILSON
Journal:  Lancet       Date:  1953-04-04       Impact factor: 79.321

5.  Synergistic action of liquorice and cortisone in Addison's and Simmonds's disease.

Authors:  J G G BORST; S P TEN HOLT; L A DE VRIES; J A MOLHUYSEN
Journal:  Lancet       Date:  1953-04-04       Impact factor: 79.321

6.  Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus.

Authors:  D S AMATUZIO; F L STUTZMAN; M J VANDERBILT; S NESBITT
Journal:  J Clin Invest       Date:  1953-05       Impact factor: 14.808

7.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

8.  The intravenous glucose tolerance test in malignant disease.

Authors:  D H BOYD; B CLAPP; M FINNEGAN
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640

  8 in total
  2 in total

Review 1.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.

Authors:  F D Henman
Journal:  Gut       Date:  1970-04       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.